pyrrolidonecarboxylic acid has been researched along with Tauopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delpech, JC; Hu, J; Ikezu, S; Ikezu, T; Ruan, Z; Van Enoo, AA; Venkatesan Kalavai, S | 1 |
1 other study(ies) available for pyrrolidonecarboxylic acid and Tauopathies
| Article | Year |
|---|---|
P2RX7 inhibitor suppresses exosome secretion and disease phenotype in P301S tau transgenic mice.
Topics: Animals; Disease Models, Animal; Exosomes; Mice; Mice, Transgenic; Microglia; Phenotype; Pyrrolidonecarboxylic Acid; Receptors, Purinergic P2X7; Tauopathies | 2020 |